
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Predicting tumor response to drugs based on gene-expression biomarkers of sensitivity learned from cancer cell lines
Yuanyuan Li, David M. Umbach, J.M. Krahn, et al.
BMC Genomics (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 46
Yuanyuan Li, David M. Umbach, J.M. Krahn, et al.
BMC Genomics (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 46
Showing 1-25 of 46 citing articles:
Celastrol in cancer therapy: Recent developments, challenges and prospects
Hannah Ying Lim, Pei Shi Ong, Lingzhi Wang, et al.
Cancer Letters (2021) Vol. 521, pp. 252-267
Closed Access | Times Cited: 80
Hannah Ying Lim, Pei Shi Ong, Lingzhi Wang, et al.
Cancer Letters (2021) Vol. 521, pp. 252-267
Closed Access | Times Cited: 80
An overview of machine learning methods for monotherapy drug response prediction
Farzaneh Firoozbakht, Behnam Yousefi, Benno Schwikowski
Briefings in Bioinformatics (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 43
Farzaneh Firoozbakht, Behnam Yousefi, Benno Schwikowski
Briefings in Bioinformatics (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 43
MAPK inhibitor sensitivity scores predict sensitivity driven by the immune infiltration in pediatric low-grade gliomas
Romain Sigaud, Thomas Albert, Caroline Heß, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 18
Romain Sigaud, Thomas Albert, Caroline Heß, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 18
Expression of the checkpoint kinase BUB1 is a predictor of response to cancer therapies
Ylenia Cicirò, Denise Ragusa, Arturo Sala
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Ylenia Cicirò, Denise Ragusa, Arturo Sala
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Advancements in Gene Structure Prediction: Innovation and Prospects of Deep Learning Models Apply in Multi-species
Tong Wang, H. J. Yang, Ting Xu, et al.
(2025) Vol. 1, Iss. 1, pp. 55-116
Closed Access
Tong Wang, H. J. Yang, Ting Xu, et al.
(2025) Vol. 1, Iss. 1, pp. 55-116
Closed Access
Q-omics: Smart Software for Assisting Oncology and Cancer Research
Jieun Lee, Young‐Ju Kim, Seonghee Jin, et al.
Molecules and Cells (2021) Vol. 44, Iss. 11, pp. 843-850
Open Access | Times Cited: 28
Jieun Lee, Young‐Ju Kim, Seonghee Jin, et al.
Molecules and Cells (2021) Vol. 44, Iss. 11, pp. 843-850
Open Access | Times Cited: 28
CACA Technical guidelines for holistic integrative management of cancer —— genetic testing
Bing Wei, Jinliang Xing, Xiaoyan Zhou, et al.
Holistic Integrative Oncology (2025) Vol. 4, Iss. 1
Open Access
Bing Wei, Jinliang Xing, Xiaoyan Zhou, et al.
Holistic Integrative Oncology (2025) Vol. 4, Iss. 1
Open Access
Predicting drug response through tumor deconvolution by cancer cell lines
Yu‐Ching Hsu, Yu‐Chiao Chiu, Tzu‐Pin Lu, et al.
Patterns (2024) Vol. 5, Iss. 4, pp. 100949-100949
Open Access | Times Cited: 3
Yu‐Ching Hsu, Yu‐Chiao Chiu, Tzu‐Pin Lu, et al.
Patterns (2024) Vol. 5, Iss. 4, pp. 100949-100949
Open Access | Times Cited: 3
Multiomics analysis identifies oxidative phosphorylation as a cancer vulnerability arising from myristoylation inhibition
Erwan Beauchamp, Jay M. Gamma, Christopher R. Cromwell, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Erwan Beauchamp, Jay M. Gamma, Christopher R. Cromwell, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Pan-cancer single-cell landscape of drug-metabolizing enzyme genes
Wei Mao, Tao Zhou, Feng Zhang, et al.
Pharmacogenetics and Genomics (2024)
Closed Access | Times Cited: 3
Wei Mao, Tao Zhou, Feng Zhang, et al.
Pharmacogenetics and Genomics (2024)
Closed Access | Times Cited: 3
Glutamine Metabolism Regulators Associated with Cancer Development and the Tumor Microenvironment: A Pan-Cancer Multi-Omics Analysis
Jingwen Zou, Kunpeng Du, Shaohua Li, et al.
Genes (2021) Vol. 12, Iss. 9, pp. 1305-1305
Open Access | Times Cited: 19
Jingwen Zou, Kunpeng Du, Shaohua Li, et al.
Genes (2021) Vol. 12, Iss. 9, pp. 1305-1305
Open Access | Times Cited: 19
The Genetic, Pharmacogenomic, and Immune Landscapes Associated with Protein Expression across Human Cancers
Chengxuan Chen, Yuan Liu, Qiang Li, et al.
Cancer Research (2023) Vol. 83, Iss. 22, pp. 3673-3680
Closed Access | Times Cited: 7
Chengxuan Chen, Yuan Liu, Qiang Li, et al.
Cancer Research (2023) Vol. 83, Iss. 22, pp. 3673-3680
Closed Access | Times Cited: 7
Enhancing cancer stage prediction through hybrid deep neural networks: a comparative study
Alina Amanzholova, Aysun Coşkun
Frontiers in Big Data (2024) Vol. 7
Open Access | Times Cited: 2
Alina Amanzholova, Aysun Coşkun
Frontiers in Big Data (2024) Vol. 7
Open Access | Times Cited: 2
Targeting neddylation and sumoylation in chemoresistant triple negative breast cancer
Reid T. Powell, Amanda L. Rinkenbaugh, Lei Guo, et al.
npj Breast Cancer (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Reid T. Powell, Amanda L. Rinkenbaugh, Lei Guo, et al.
npj Breast Cancer (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Pattern‐centric transformation of omics data grounded on discriminative gene associations aids predictive tasks in TCGA while ensuring interpretability
André Patrício, Rafael S. Costa, Rui Henriques
Biotechnology and Bioengineering (2024) Vol. 121, Iss. 9, pp. 2881-2892
Closed Access | Times Cited: 2
André Patrício, Rafael S. Costa, Rui Henriques
Biotechnology and Bioengineering (2024) Vol. 121, Iss. 9, pp. 2881-2892
Closed Access | Times Cited: 2
Acetalax (Oxyphenisatin Acetate, NSC 59687) and Bisacodyl Cause Oncosis in Triple-Negative Breast Cancer Cell Lines by Poisoning the Ion Exchange Membrane Protein TRPM4
Makito Mizunuma, Christophe E. Redon, Liton Kumar Saha, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 8, pp. 2101-2111
Open Access | Times Cited: 2
Makito Mizunuma, Christophe E. Redon, Liton Kumar Saha, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 8, pp. 2101-2111
Open Access | Times Cited: 2
miRNASNP-v4: a comprehensive database for miRNA-related SNPs across 17 species
Wen Cao, Jiaxin He, Jing Feng, et al.
Nucleic Acids Research (2024) Vol. 53, Iss. D1, pp. D1066-D1074
Open Access | Times Cited: 2
Wen Cao, Jiaxin He, Jing Feng, et al.
Nucleic Acids Research (2024) Vol. 53, Iss. D1, pp. D1066-D1074
Open Access | Times Cited: 2
A novel qualitative signature based on lncRNA pairs for prognosis prediction in hepatocellular carcinoma
Xiaoyun Bu, Luyao Ma, Shuang Liu, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Xiaoyun Bu, Luyao Ma, Shuang Liu, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Interactive enhancer hubs (iHUBs) mediate transcriptional reprogramming and adaptive resistance in pancreatic cancer
Feda H. Hamdan, Amro M. Abdelrahman, Ana P. Kutschat, et al.
Gut (2023) Vol. 72, Iss. 6, pp. 1174-1185
Open Access | Times Cited: 6
Feda H. Hamdan, Amro M. Abdelrahman, Ana P. Kutschat, et al.
Gut (2023) Vol. 72, Iss. 6, pp. 1174-1185
Open Access | Times Cited: 6
Next-generation sequencing reveals altered gene expression and enriched pathways in triple-negative breast cancer cells treated with oleuropein and oleocanthal
Paraskevi Karousi, Christos K. Kontos, Panagiota Papakotsi, et al.
Functional & Integrative Genomics (2023) Vol. 23, Iss. 4
Open Access | Times Cited: 6
Paraskevi Karousi, Christos K. Kontos, Panagiota Papakotsi, et al.
Functional & Integrative Genomics (2023) Vol. 23, Iss. 4
Open Access | Times Cited: 6
Unraveling the prognostic significance and molecular characteristics of tumor-infiltrating B lymphocytes in clear cell renal cell carcinoma through a comprehensive bioinformatics analysis
Youwei Yue, Xinyi Cai, Changhao Lu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Youwei Yue, Xinyi Cai, Changhao Lu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
PancanQTLv2.0: a comprehensive resource for expression quantitative trait loci across human cancers
Chengxuan Chen, Yuan Liu, Mei Luo, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. D1, pp. D1400-D1406
Open Access | Times Cited: 3
Chengxuan Chen, Yuan Liu, Mei Luo, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. D1, pp. D1400-D1406
Open Access | Times Cited: 3
Bioinformatics Analysis of the Molecular Mechanism and Potential Treatment Target of Ankylosing Spondylitis
Fanyan Meng, Ningna Du, Dao-Ming Xu, et al.
Computational and Mathematical Methods in Medicine (2021) Vol. 2021, pp. 1-11
Open Access | Times Cited: 6
Fanyan Meng, Ningna Du, Dao-Ming Xu, et al.
Computational and Mathematical Methods in Medicine (2021) Vol. 2021, pp. 1-11
Open Access | Times Cited: 6
Molecular landscapes of glioblastoma cell lines revealed a group of patients that do not benefit from WWOX tumor suppressor expression
Żaneta Kałuzińska‐Kołat, Damian Kołat, Katarzyna Kośla, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 2
Żaneta Kałuzińska‐Kołat, Damian Kołat, Katarzyna Kośla, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 2
Computational Tactics for Precision Cancer Network Biology
Heewon Park, Satoru Miyano
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14398-14398
Open Access | Times Cited: 3
Heewon Park, Satoru Miyano
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14398-14398
Open Access | Times Cited: 3